Company Pharmax Srl with Fiscal Code 15981226
recorded a turnover of 2024 of
129.440,
with a net profit of
2.270
and having an average number of employees of
2.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Pharmax Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
144.307
140.924
142.545
149.738
148.496
134.742
124.786
133.455
129.080
129.440
Total Income - EUR
144.312
140.932
142.552
149.742
149.119
143.502
125.124
134.498
129.950
129.852
Total Expenses - EUR
128.854
127.029
129.745
137.217
130.580
115.891
98.881
108.734
115.351
125.122
Gross Profit/Loss - EUR
15.458
13.902
12.806
12.525
18.539
27.611
26.243
25.764
14.598
4.730
Net Profit/Loss - EUR
12.985
11.678
11.305
11.028
17.048
26.450
25.140
24.621
13.325
2.270
Employees
2
2
2
2
2
2
2
2
2
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 0.8%, from 129.080 euro in the year 2023, to 129.440 euro in 2024.
The Net Profit decreased by -10.980 euro, from 13.325 euro in 2023, to 2.270 in the last year.
Check the financial reports for the company - Pharmax Srl
Financial Rating - PHARMAX SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Pharmax Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Pharmax Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Pharmax Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
52.173 euro in 2024 which includes Inventories of
34.569 euro, Receivables of
15.227 euro and cash availability of
2.378 euro.
The company's Equity was valued at
9.665 euro, while total Liabilities amounted to
51.320 euro.
Equity decreased by -5.509 euro, from 15.259 euro in 2023, to 9.665 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Pharmax Srl